• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾病综合征:利妥昔单抗治疗难治性肾病综合征的疗效。

Nephrotic syndrome: Efficacy of rituximab in challenging nephrotic syndrome.

机构信息

Division of Paediatric Nephrology, Children's Hospital Los Angeles, University of Southern California, 4650 Sunset Boulevard, Los Angeles, CA 90027, USA.

Division of Paediatric Nephrology, Rady Children's Hospital, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0630, USA.

出版信息

Nat Rev Nephrol. 2015 May;11(5):257-8. doi: 10.1038/nrneph.2015.26. Epub 2015 Mar 10.

DOI:10.1038/nrneph.2015.26
PMID:25752834
Abstract

A new trial provides further evidence that rituximab treatment can reduce the risk of relapse in children with steroid-dependent idiopathic nephrotic syndrome. Addition of a single infusion of rituximab to steroid therapy was associated with a decrease in proteinuria at 3 months and a significant increase in the relapse-free period.

摘要

一项新的试验提供了进一步的证据,表明利妥昔单抗治疗可以降低类固醇依赖型特发性肾病综合征儿童的复发风险。在类固醇治疗的基础上加用单次利妥昔单抗输注可使 3 个月时蛋白尿减少,并显著延长无复发期。

相似文献

1
Nephrotic syndrome: Efficacy of rituximab in challenging nephrotic syndrome.肾病综合征:利妥昔单抗治疗难治性肾病综合征的疗效。
Nat Rev Nephrol. 2015 May;11(5):257-8. doi: 10.1038/nrneph.2015.26. Epub 2015 Mar 10.
2
Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial.利妥昔单抗治疗激素依赖型肾病综合征患儿:一项多中心、开放标签、非劣效性随机对照试验
J Am Soc Nephrol. 2015 Sep;26(9):2259-66. doi: 10.1681/ASN.2014080799. Epub 2015 Jan 15.
3
Human or Chimeric Monoclonal Anti-CD20 Antibodies for Children with Nephrotic Syndrome: A Superiority Randomized Trial.人源化或嵌合型抗 CD20 单克隆抗体治疗儿童肾病综合征:一项优效性随机临床试验。
J Am Soc Nephrol. 2021 Oct;32(10):2652-2663. doi: 10.1681/ASN.2021040561. Epub 2021 Sep 20.
4
Study protocol: multicenter double-blind, randomized, placebo-controlled trial of rituximab for the treatment of childhood-onset early-stage uncomplicated frequently relapsing or steroid-dependent nephrotic syndrome (JSKDC10 trial).研究方案:利妥昔单抗治疗儿童起病早期单纯型频复发或激素依赖型肾病综合征的多中心双盲、随机、安慰剂对照试验(JSKDC10 试验)。
BMC Nephrol. 2019 Aug 2;20(1):293. doi: 10.1186/s12882-019-1470-3.
5
Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children.抗CD20抗体用于儿童特发性肾病综合征
Clin J Am Soc Nephrol. 2016 Apr 7;11(4):710-20. doi: 10.2215/CJN.08500815. Epub 2015 Nov 19.
6
Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome.随机临床试验比较重复利妥昔单抗疗程与单次利妥昔单抗疗程后序贯霉酚酸酯维持治疗在儿童激素依赖性肾病综合征中的疗效和安全性。
BMC Nephrol. 2020 Nov 30;21(1):520. doi: 10.1186/s12882-020-02153-5.
7
Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.用于儿童激素敏感型肾病综合征的非皮质类固醇免疫抑制药物。
Cochrane Database Syst Rev. 2020 Apr 16;4(4):CD002290. doi: 10.1002/14651858.CD002290.pub5.
8
Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.儿童类固醇敏感型肾病综合征的非皮质类固醇类免疫抑制药物。
Cochrane Database Syst Rev. 2024 Nov 8;11(11):CD002290. doi: 10.1002/14651858.CD002290.pub6.
9
Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials.利妥昔单抗治疗激素敏感型肾病综合征:临床试验的经验教训。
Pediatr Nephrol. 2018 Sep;33(9):1449-1455. doi: 10.1007/s00467-017-3746-9. Epub 2017 Jul 17.
10
Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol.在依赖类固醇和钙调神经磷酸酶抑制剂的儿童特发性肾病综合征中比较奥法木单抗与利妥昔单抗的随机对照试验:研究方案
BMJ Open. 2017 Mar 17;7(3):e013319. doi: 10.1136/bmjopen-2016-013319.

引用本文的文献

1
A mild form of rituximab-associated lung injury in two adolescents treated for nephrotic syndrome.两名接受肾病综合征治疗的青少年出现的轻度利妥昔单抗相关肺损伤。
BMJ Case Rep. 2015 Dec 9;2015:bcr2015212694. doi: 10.1136/bcr-2015-212694.

本文引用的文献

1
Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial.利妥昔单抗治疗激素依赖型肾病综合征患儿:一项多中心、开放标签、非劣效性随机对照试验
J Am Soc Nephrol. 2015 Sep;26(9):2259-66. doi: 10.1681/ASN.2014080799. Epub 2015 Jan 15.
2
Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.利妥昔单抗治疗儿童起病、复杂、频繁复发型肾病综合征或激素依赖型肾病综合征:一项多中心、双盲、随机、安慰剂对照试验。
Lancet. 2014 Oct 4;384(9950):1273-81. doi: 10.1016/S0140-6736(14)60541-9. Epub 2014 Jun 22.
3
Abatacept in B7-1-positive proteinuric kidney disease.
阿巴西普治疗 B7-1 阳性蛋白尿性肾病。
N Engl J Med. 2013 Dec 19;369(25):2416-23. doi: 10.1056/NEJMoa1304572. Epub 2013 Nov 8.
4
The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual patient.KDIGO 肾小球肾炎实践指南:从(指南)字里行间看问题——针对个体患者的应用。
Kidney Int. 2012 Oct;82(8):840-56. doi: 10.1038/ki.2012.280. Epub 2012 Aug 15.
5
Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.利妥昔单抗靶向复发性局灶节段性肾小球硬化的足细胞。
Sci Transl Med. 2011 Jun 1;3(85):85ra46. doi: 10.1126/scitranslmed.3002231.
6
Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial.利妥昔单抗治疗儿童激素和钙调磷酸酶抑制剂依赖型肾病综合征的短期疗效:一项随机对照试验。
Clin J Am Soc Nephrol. 2011 Jun;6(6):1308-15. doi: 10.2215/CJN.09421010. Epub 2011 May 12.
7
Should we consider MMF therapy after rituximab for nephrotic syndrome?我们是否应该考虑在利妥昔单抗治疗肾病综合征后使用 MMF 治疗?
Pediatr Nephrol. 2011 Oct;26(10):1759-62. doi: 10.1007/s00467-011-1894-x. Epub 2011 May 1.
8
The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.肾足细胞的肌动蛋白细胞骨架是环孢素A抗蛋白尿作用的直接靶点。
Nat Med. 2008 Sep;14(9):931-8. doi: 10.1038/nm.1857.